Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$213K Buy
+3,165
New +$211K 0.03% 433
2026
Q1
Sell
-3,071
Closed -$204K 496
2025
Q4
$204K Buy
+3,071
New +$199K 0.03% 431

Other funds holding DXCM

Optas LLC's DXCM Position: Q2 2026 in Review

Optas LLC opened a new position in DexCom (DXCM) in Q2 2026: 3,165 shares worth $213K. The stake represents 0.03% of the portfolio and ranks #433 among its holdings. This is a return to the name: Optas LLC previously reported a position in DXCM as recently as Q4 2025.

Optas LLC first reported a position in DXCM in Q4 2025 and has held it in 2 quarters since. 206 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Optas LLC held 3,165 shares of DexCom worth $213K as of Q2 2026.
  • DexCom was a new Optas LLC position in Q2 2026.
  • DexCom made up 0.03% of Optas LLC's portfolio in Q2 2026, its #433 holding.
  • Optas LLC first reported a position in DexCom in Q4 2025 and has held it in 2 quarters since.
  • 206 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Optas LLC's 13F filing for Q2 2026, filed 21 Jul 2026.